| 发明名称 | Organic compounds | ||
| 摘要 | The present invention relates to a new use of phosphodiesterase 1 (PDE1) inhibitors for the treatment of psychosis, schizophrenia, schizoaffective disorder, schizophreniform disorder, psychotic disorder, delusional disorder, mania, or bipolar disorder. | ||
| 申请公布号 | US9468637(B2) | 申请公布日期 | 2016.10.18 |
| 申请号 | US201013319807 | 申请日期 | 2010.05.13 |
| 申请人 | INTRA-CELLULAR THERAPIES, INC. | 发明人 | Fienberg Allen A.;Wennogle Lawrence P.;Mates Sharon |
| 分类号 | A01N43/90;A61K31/519;C07D471/04;C07D471/22;A01N43/66;A61K31/53;A61K31/495 | 主分类号 | A01N43/90 |
| 代理机构 | Hoxie & Associates LLC | 代理人 | Hoxie & Associates LLC |
| 主权项 | 1. A method of treatment for psychosis, schizoaffective disorder, schizophreniform disorder, psychotic disorder, delusional disorder, mania or bipolar disorder comprising administering an effective amount of a PDE 1 inhibitor to a patient in need thereof wherein the PDE 1 inhibitor is: in free or salt form, including its enantiomers, diastereoisomers and racemates. | ||
| 地址 | New York NY US | ||